As of 2024-12-13, the Fair Value of Deciphera Pharmaceuticals Inc (DCPH) is -11.01 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 25.59 USD, the upside of Deciphera Pharmaceuticals Inc is -143.02%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -192.26 | -266.49 | -299.96 | -178.93 | -194.94 | -226.52 |
| YoY growth | -92.54% | -38.61% | -12.56% | 40.35% | -8.95% | -22.46% |
| Market Cap (mil) | 2,213.02 |
| P/E | |
| Forward P/E |
| EPS | -2.20 |
| Avg earnings growth rate | -22.46% |
| TTM earnings | -190.42 |